Cargando…

AB051. Comparison of urine cytology and UroVysion FISH for upper tract urothelial carcinoma detection in Chinese patients

OBJECTIVE: UroVysion FISH has been used for screening bladder cancer in western countries, but still limited in China. This non-invasive assay is also practical for detecting upper tract urothelial carcinoma. The present study evaluates the effectiveness of UroVysion and urine cytology in detecting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Weibin, Jun, Lin, Zhao, Jimao, Xu, Xiuhong, Chi, Qiang, Wang, Zhiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2016
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842661/ http://dx.doi.org/10.21037/tau.2016.s051

Ejemplares similares

A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection
por: Lavery, Hugh J., et al.
Publicado: (2017)

UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study
por: Dodurga, Yavuz, et al.
Publicado: (2013)

Evaluation of UroVysion for Urachal Carcinoma Detection
por: Hu, Zhiquan, et al.
Publicado: (2020)

Refined pancreatobiliary UroVysion criteria and an approach for further optimization
por: Mettman, Daniel, et al.
Publicado: (2021)

UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives
por: Nagai, Takashi, et al.
Publicado: (2021)

Comparative study of ProEx C immunocytochemistry and UroVysion fluorescent in-situ hybridization assays on urine cytology specimens
por: Chang, Sue, et al.
Publicado: (2015)

Performance of the UroVysion (®) FISH assay for the diagnosis of malignant effusions using two cutoff strategies
por: Rosolen, Débora C. B., et al.
Publicado: (2018)

UroVysion(™) fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages
por: Ke, Chunjin, et al.
Publicado: (2023)

A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets
por: Breen, Vivienne, et al.
Publicado: (2015)

Can Reflex UroVysion fluorescence in situ hybridization predict tumor recurrence during follow-up?
por: Kurien, Annamma, et al.
Publicado: (2007)

UroVysion(TM) Fluorescence In Situ Hybridization in Urological Cancers: A Narrative Review and Future Perspectives
por: Ke, Chunjin, et al.
Publicado: (2022)

Clinical Evaluation of Two Non-Invasive Genetic Tests for Detection and Monitoring of Urothelial Carcinoma: Validation of UroVysion and Xpert Bladder Cancer Detection Test
por: Kavcic, Niko, et al.
Publicado: (2022)

Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients
por: Nagai, Takashi, et al.
Publicado: (2019)

Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan
por: Ikeda, Atsushi, et al.
Publicado: (2020)

Diagnostic value comparison of CellDetect, fluorescent in situ hybridization (FISH), and cytology in urothelial carcinoma
por: Shang, Donghao, et al.
Publicado: (2021)

Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy
por: Liu, Wen, et al.
Publicado: (2020)

AB051. Technical improvement of HoLEP and prevention strategies of postoperative incontinence
por: Ding, Mingxia, et al.
Publicado: (2015)

AB051. The application of traditional Chinese medicine nursing in neurogenic bladder dysfunction
por: Xie, Li
Publicado: (2018)

Is Diagnosis of Low-Grade Urothelial Carcinoma Possible in Urine Cytology?
por: Bansal, Saloni, et al.
Publicado: (2021)

AB049. The importance of Uro-Andro-check in sexual medicine
por: Soebadi, Doddy M.
Publicado: (2015)

Acidic Urine Is Associated With Poor Prognosis of Upper Tract Urothelial Carcinoma
por: Han, Jang Hee, et al.
Publicado: (2022)

Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?
por: Bier, Simone, et al.
Publicado: (2018)

Reactivation of BK Polyomavirus in Urine Cytology Is Not Associated with Urothelial Cell Carcinoma
por: Klufah, Faisal, et al.
Publicado: (2020)

Micropapillary urothelial carcinoma: Cytologic features in a retrospective series of urine specimens
por: Heymann, Jonas John, et al.
Publicado: (2013)

Upper tract urinary cytology to detect upper tract urothelial carcinoma: Using the Johns Hopkins Hospital template and evaluation of its feasibility
por: Chen, Longwen, et al.
Publicado: (2015)

AB070. The risk factors for intravesical recurrence after upper-tract urothelial carcinoma surgery
por: Zeng, Shuxiong, et al.
Publicado: (2018)

Urovysion FISH Could Be Effective and Useful Method to Confirm the Identity of Cultured Circulating Tumor Cells from Bladder Cancer Patients
por: Kim, Tae-Jung, et al.
Publicado: (2019)

Evaluation of Urine Cytology in Urothelial Carcinoma Patients: A Comparison of CellprepPlus® Liquid-Based Cytology and Conventional Smear
por: Son, Seung-Myoung, et al.
Publicado: (2012)

Immunohistochemical detection of hTERT in urothelial lesions: a potential adjunct to urine cytology
por: Khalbuss, Walid, et al.
Publicado: (2006)

Urine and bladder washing cytology for detection of urothelial carcinoma: standard test with new possibilities
por: Flezar, Margareta Strojan
Publicado: (2010)

(PO-051) Catatonic with COVID-19
por: Patel, Prit, et al.
Publicado: (2022)

AB051. Simultaneous bilateral retroperitoneal laparoscopic nephron sparing surgery: a case report and evaluation of the technique
por: Tong, Ming
Publicado: (2017)

Nefro-Uro /
Publicado: (2018)

AB162. Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma
por: Xiong, Gengyan, et al.
Publicado: (2015)

AB90. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of methylation status
por: Zhang, Lei, et al.
Publicado: (2014)

Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)
por: Bersanelli, Melissa, et al.
Publicado: (2021)

Hema-Uro-Chrome—A New Laboratory Test for Cancer and Sarcoma; from the Urine
Publicado: (1914)

AB45. URO-MCP-1 mice: a model demonstrating UCPPS hallmark symptoms
por: Luo, Yi
Publicado: (2014)

AB87. Evaluating the impact of preoperative anemia on the prognosis of upper tract urothelial carcinoma following radical nephroureterectomy
por: Xing, Yunchao, et al.
Publicado: (2014)

AB050. Prognostic relevance of preoperative platelet-to-albumin ratio in patients with upper urinary tract urothelial carcinoma
por: Zhao, Hongda, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_epk577e8u2q093qtffnc0laqap